HomeCompareFOMO vs JNJ

FOMO vs JNJ: Dividend Comparison 2026

FOMO yields 11.89% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FOMO wins by $23.8K in total portfolio value
10 years
FOMO
FOMO
● Live price
11.89%
Share price
$16.83
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.8K
Annual income
$2,496.66
Full FOMO calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FOMO vs JNJ

📍 FOMO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFOMOJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FOMO + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FOMO pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FOMO
Annual income on $10K today (after 15% tax)
$1,010.40/yr
After 10yr DRIP, annual income (after tax)
$2,122.16/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, FOMO beats the other by $1,418.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FOMO + JNJ for your $10,000?

FOMO: 50%JNJ: 50%
100% JNJ50/50100% FOMO
Portfolio after 10yr
$31.9K
Annual income
$1,662.22/yr
Blended yield
5.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FOMO
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FOMO buys
0
JNJ buys
0
No recent congressional trades found for FOMO or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFOMOJNJ
Forward yield11.89%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$43.8K$20.0K
Annual income after 10y$2,496.66$827.78
Total dividends collected$18.3K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FOMO vs JNJ ($10,000, DRIP)

YearFOMO PortfolioFOMO Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,889$1,188.71$10,676$355.77+$1.2KFOMO
2$14,042$1,320.77$11,407$389.39+$2.6KFOMO
3$16,482$1,457.90$12,198$426.53+$4.3KFOMO
4$19,236$1,599.36$13,056$467.62+$6.2KFOMO
5$22,327$1,744.40$13,987$513.12+$8.3KFOMO
6$25,782$1,892.24$14,998$563.56+$10.8KFOMO
7$29,628$2,042.13$16,098$619.52+$13.5KFOMO
8$33,896$2,193.30$17,295$681.69+$16.6KFOMO
9$38,614$2,345.04$18,599$750.82+$20.0KFOMO
10$43,813$2,496.66$20,022$827.78+$23.8KFOMO

FOMO vs JNJ: Complete Analysis 2026

FOMOStock

The fund is an actively managed exchange traded fund that will invest primarily in equity securities of U.S., foreign, and emerging market companies of any market capitalization and SPACs. It invests, on a short-term basis, in inverse and leveraged ETFs that seek to provide the inverse performance of stock indices, treasury bonds, and volatility ETFs. The fund will invest in fixed income ETFs that primarily invest in domestic and foreign fixed income securities of any credit rating maturity and duration.

Full FOMO Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FOMO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FOMO vs SCHDFOMO vs JEPIFOMO vs OFOMO vs KOFOMO vs MAINFOMO vs ABBVFOMO vs MRKFOMO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.